Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26970723

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Apr 30
First author
Fehrenbacher L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Apr 30;387(10030):1795-6. doi: 10.1016/S0140-6736(16)00700-5.
    note
    Source null
    related pmid
    26972842
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 May;13(5):266. doi: 10.1038/nrclinonc.2016.52.
    note
    Source null
    related pmid
    27030073
    relationship
    Comment in

Authors and identifiers

  1. name
    Fehrenbacher L
    type
    Author
  2. name
    Spira A
    type
    Author
  3. name
    Ballinger M
    type
    Author
  4. name
    Kowanetz M
    type
    Author
  5. name
    Vansteenkiste J
    type
    Author
  6. name
    Mazieres J
    type
    Author
  7. name
    Park K
    type
    Author
  8. name
    Smith D
    type
    Author
  9. name
    Artal-Cortes A
    type
    Author
  10. name
    Lewanski C
    type
    Author
  11. name
    Braiteh F
    type
    Author
  12. name
    Waterkamp D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fehrenbacher L
    type
    Author
  2. name
    Spira A
    type
    Author
  3. name
    Ballinger M
    type
    Author
  4. name
    Kowanetz M
    type
    Author
  5. name
    Vansteenkiste J
    type
    Author
  6. name
    Mazieres J
    type
    Author
  7. name
    Park K
    type
    Author
  8. name
    Smith D
    type
    Author
  9. name
    Artal-Cortes A
    type
    Author
  10. name
    Lewanski C
    type
    Author
  11. name
    Braiteh F
    type
    Author
  12. name
    Waterkamp D
    type
    Author
bibliography ids
  1. nci-bib-3f3b3fee4c96412c11801241
book metadata
content sha256
db56a3bfcad01392424ab15ad845ab7152b56f8847589a9ab86650ee3e50202f
document type
citation
dois
  1. 10.1016/S0140-6736(16)00587-0
electronic publication date
display
2016 Mar 10
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:26970723
immutable id
pubmed:26970723@db56a3bfcad01392424ab15ad845ab7152b56f8847589a9ab86650ee3e50202f
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10030
name
Lancet (London, England)
nlm unique id
2985213R
pages
1837-46
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Apr 30;387(10030):1795-6. doi: 10.1016/S0140-6736(16)00700-5.
    note
    Source null
    related pmid
    26972842
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 May;13(5):266. doi: 10.1038/nrclinonc.2016.52.
    note
    Source null
    related pmid
    27030073
    relationship
    Comment in
outcomes validated
false
pmid
26970723
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
a66df8adbb6191eb33685080361c014071f0702c65c5c88dd3a74b0150fdd33a
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Apr 30
precision
day
year
2016
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26970723/
title
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Preserved source evidence · Not medical advice